During viral infections, STAT1 signaling regulates the balance of ILC subsets, promoting antiviral IFN-γ+ ILC1s while suppressing potentially immunopathologic IL-5+ and IL-13+ ILC2s and IL-17A+ ILC3s. Here, IL13 is linked to viral infectious disease.